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Foreword 
The Department of Health asked the National Institute for Health and Clinical 
Excellence (NICE or the Institute) to produce public health guidance on 
interventions to reduce the transmission of chlamydia (including screening) 
and other sexually transmitted infections (STIs) (including HIV) and to reduce 
the rate of under 18 conceptions, especially among vulnerable and at risk 
groups. This guidance focuses on one to one interventions to prevent STIs 
and under 18 conceptions.  
The guidance is for NHS and non-NHS professionals who have a direct or 
indirect role in, or responsibility for, sexual health services. This includes 
those working in local authorities and the education, community, voluntary and 
private sectors. 
The Public Health Interventions Advisory Committee (PHIAC) has considered 
the reviews of the evidence, an economic appraisal, stakeholder comments 
and the results of fieldwork in developing these recommendations. 
Details of PHIAC membership are given in appendix C. The methods used to 
develop the guidance are summarised in appendix D. Supporting documents 
used in the preparation of this document are listed in appendix E. Full details 
of the evidence collated, including fieldwork data and activities and 
stakeholder comments, are available on the NICE website, along with a list of 
the stakeholders involved and the Institute’s supporting process and methods 
manuals. The website address is: www.nice.org.uk
  3
Contents  
1 Recommendations....................................................................................5 
2 Public health need and practice..............................................................10 
3 Considerations........................................................................................16 
4 Implementation .......................................................................................18 
5 Recommendations for research..............................................................19 
6 Updating the recommendations ..............................................................19 
7 Related NICE guidance ..........................................................................20 
8 References .............................................................................................20 
Appendix A: recommendations for policy and practice and supporting 
evidence statements ......................................................................................22 
Appendix B: gaps in the evidence..................................................................36 
Appendix C: membership of the Public Health Interventions Advisory 
Committee (PHIAC), the NICE Project Team and external contractors .........38 
Appendix D: summary of the methods used to develop this guidance...........42 
Appendix E: supporting documents ...............................................................50 
 
  4
1 Recommendations  
This document constitutes the Institute’s formal guidance on one to one 
interventions to prevent sexually transmitted infections (STIs) and under 18 
conceptions. The recommendations in this section are presented without any 
reference to evidence statements. Appendix A repeats the recommendations 
and lists their linked evidence statements. 
Recommendation 1 
Who is the target population? 
Key groups at risk of STIs including: 
• men who have sex with men 
• people who have come from or who have visited areas of high HIV 
prevalence.  
Behaviours that increase the risk of STIs include: 
• misuse of alcohol and/or substances 
• early onset of sexual activity  
• unprotected sex and frequent change of and/or multiple sexual partners. 
Who should take action? 
Health professionals working in: 
• general practice  
• genito-urinary medicine (GUM)  
• community health services (including community contraceptive services) 
• voluntary and community organisations 
• school clinics.  
What action should they take? 
• Identify individuals at high risk of STIs using their sexual history. 
Opportunities for risk assessment may arise during consultations on 
contraception, pregnancy or abortion, and when carrying out a cervical 
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smear test, offering an STI test or providing travel immunisation. Risk 
assessment could also be carried out during routine care or when a new 
patient registers.  
• Have one to one structured discussions with individuals at high risk of 
STIs (if trained in sexual health), or arrange for these discussions to take 
place with a trained practitioner.   
Recommendation 2 
Who is the target population? 
Key groups at risk of STIs including: 
• men who have sex with men 
• people who have come from or who have visited areas of high HIV 
prevalence.  
Behaviours that increase the risk of STIs include: 
• misuse of alcohol and/or substances 
• early onset of sexual activity  
• unprotected sex and frequent change of and/or multiple sexual partners. 
Who should take action? 
Health professionals trained in sexual health who work in: 
• general practice  
• GUM  
•  community health services (including community contraceptive services)  
• voluntary and community organisations 
•  school clinics.  
What action should they take? 
• Have one to one structured discussions with individuals at high risk of STIs. 
The discussions should be structured on the basis of behaviour change 
theories. They should address factors that can help reduce risk-taking and 
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improve self-efficacy and motivation. Ideally, each session should last at 
least 15–20 minutes. The number of sessions will depend on individual 
need. 
• For details of a range of behaviour change theories see ‘Predicting health 
behaviour’ (Conner and Norman 2005).  
Recommendation 3 
Who is the target population? 
Patients with an STI  
Who should take action? 
• Health professionals working in general practice, GUM and community 
health services (including community contraceptive services), voluntary and 
community organisations and school clinics. (However, they may need to 
refer the patient to a specialist.) 
• Specialists with responsibility for helping to contact, test and treat partners 
of patients with an STI (partner notification). They may be sexual health 
advisers, general practitioners (GPs) or practice nurses providing 
enhanced sexual health services, chlamydia screening coordinators or 
GUM clinicians. 
What action should they take? 
• Help patients with an STI to get their partners tested and treated (partner 
notification), when necessary. This support should be tailored to meet the 
patient’s individual needs.   
• If necessary, refer patients to a specialist with responsibility for partner 
notification. (Partner notification may be undertaken by the health 
professional or by the patient.) 
• Provide the patient and their partners with infection-specific information, 
including advice about possible re-infection. For chlamydia infection, also 
consider providing a home sampling kit.  
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Recommendation 4 
Who is the target population? 
Population served by a PCT 
Who should take action? 
PCT commissioners  
What action should they take? 
• Ensure that sexual health services, including contraceptive and abortion 
services, are in place to meet local needs. All services should include 
arrangements for the notification, testing, treatment and follow-up of 
partners of people who have an STI (partner notification). 
• Define the role and responsibility of each service in relation to partner 
notification (including referral pathways).  
• Ensure staff are trained.  
• Ensure there is an audit and monitoring framework in place.  
Recommendation 5 
Who is the target population? 
Vulnerable young people aged under 18. This may include young people: 
• from disadvantaged backgrounds 
• who are in – or leaving – care  
• who have low educational attainment.  
For a more detailed definition of vulnerable young people see Department for 
Education and Skills (2006) ‘Teenage pregnancy: accelerating the strategy to 
2010’. 
Who should take action? 
• GPs, nurses and other clinicians working in healthcare settings such as 
primary care, community contraceptive services, antenatal and postnatal 
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care, abortion and GUM services, drug/alcohol misuse and youth clinics, 
and pharmacies.  
• GPs, nurses and other clinicians working in non-healthcare settings such 
as schools and other education and outreach centres.  
What action should they take? 
• Where appropriate, provide one to one sexual health advice on:   
− how to prevent and/or get tested for STIs and how to prevent 
unwanted pregnancies 
- all methods of reversible contraception, including long-acting 
reversible contraception (LARC) (in line with NICE clinical 
guideline 30) 
- how to get and use emergency contraception 
- other reproductive issues and concerns. 
• Provide supporting information on the above in an appropriate format.   
Recommendation 6 
Who is the target population? 
Vulnerable young women aged under 18 who are pregnant or who are already 
mothers. This may include young women:  
• from disadvantaged backgrounds 
• who are in – or leaving – care  
• who have low educational attainment.  
For a more detailed definition of vulnerable young people see Department for 
Education and Skills (2006) ‘Teenage pregnancy: accelerating the strategy to 
2010’. 
Who should take action? 
Midwives and health visitors who provide antenatal, postnatal and child 
development services  
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What action should they take? 
• Regularly visit vulnerable women aged under 18 who are pregnant or who 
are already mothers.  
• Discuss with them and their partner (where appropriate) how to prevent or 
get tested for STIs and how to prevent unwanted pregnancies. The 
discussion should cover: 
- all methods of reversible contraception, including LARC (in line 
with NICE clinical guideline 30), and how to get and use 
emergency contraception  
- health promotion advice, in line with NICE guidance on postnatal 
care (NICE clinical guideline 37) 
- opportunities for returning to education, training and employment 
in the future. 
• Provide supporting information in an appropriate format.  
• Where appropriate, refer the young woman to the relevant agencies, 
including services concerned with reintegration into education and work.  
2 Public health need and practice 
Sexually transmitted infections  
Sexual health in the UK has deteriorated over the last 12 years, with large 
increases in many STIs. The diagnosis of chlamydia in GUM clinics has 
increased by over 300% (from 32,288 in 1995 to 104,155 in 2004), and 
gonorrhoea by over 200% (from 10,580 in 1995 to 22,335 in 2004)  
(HPA 2005). In addition, the incidence of HIV has increased more than 
threefold, from 2500 cases diagnosed in 1995 to just over 7000 in 2005 (HPA 
2006a).  
Overall, the number of STIs and other conditions diagnosed in GUM clinics in 
the UK increased by 3% between 2004–2005 (from 751,282 to 790,387) (HPA 
2006b).  
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Some of this rise may be due to the greater availability and increased 
sensitivity of tests and to increased awareness of the services available. It 
may also reflect significant changes in people’s knowledge, attitudes and 
patterns of sexual behaviour. The second ‘National survey of sexual attitudes 
and lifestyles’ (NATSAL 2000) provides the most recent data on sexual 
behaviour in Britain. Since 1990, first intercourse is taking place at a younger 
age, a greater proportion of people have multiple partners, and a greater 
proportion of men report having had a same sex partner (Johnson et al. 
2001). 
Risky sexual behaviour may be influenced by a number of factors: 
• low self-esteem 
• lack of skills (for example, in using condoms) 
• lack of negotiation skills (for example, to say ‘no’ to sex without 
condoms) 
• lack of knowledge about the risks of different sexual behaviours 
• availability of resources, such as condoms or sexual health services 
• peer pressure 
• attitudes (and prejudices) of society which may affect access to services. 
(Ellis et al. 2003)  
Under 18 conceptions  
England's under 18 and under 16 conception rates have fallen by 11.1% and 
15.2% respectively since the introduction of the ‘Teenage pregnancy strategy’ 
in 1998. Rates are now at their lowest level for 20 years (TPU 2006). 
However, the UK still has the highest rate of teenage pregnancy in western 
Europe. In 2004, there were 39,545 under 18 conceptions in England and 
41% ended in abortion. In the same year, there were 7179 under 16 
conceptions and 57.6% ended in abortion.  
Inequalities  
Sexual health problems disproportionately affect those experiencing poverty 
and social exclusion. Individuals and groups who find it most difficult to access 
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services include asylum seekers and refugees, sex workers and their clients, 
those who are homeless and young people in – or leaving – care. The highest 
burden is borne by men who have sex with men, some black and minority 
ethnic groups and young people. 
For some young people, becoming a parent is a positive choice. However, 
teenage pregnancy is often associated with poor health and social outcomes 
for both the mother and child. Young mothers are more likely to suffer 
postnatal depression and less likely to complete their education. Children born 
to teenage parents are less likely to be breastfed, more likely to live in poverty 
and more likely to become teenage parents themselves (Botting et al. 1998). 
The ‘Teenage pregnancy strategy’ has highlighted the following risk factors 
which increase the likelihood of teenage pregnancy.  
• Risky behaviours. These include:  
– early onset of sexual activity  
– poor contraceptive use   
– a mental health problem, a conduct disorder and/or  
involvement in crime   
– alcohol and substance misuse  
– already a teenage mother or had an abortion. 
• Education-related factors:  
– low education attainment or no qualifications 
– disengagement from school. 
• Family/background: 
– living in care 
– daughter of a teenage mother 
– daughter of a mother who has low educational aspirations for 
them 
– belonging to a particular ethnic group (in the 2001 census, ‘mixed 
white’, ‘black Caribbean’, ‘other black’ and ‘white British’ were 
over-represented among teenage mothers). 
(DfES 2006) 
  12
  13
The risk of an STI or an unintended pregnancy is associated with:   
• high numbers of partners 
• high rate of partner change 
• unsafe sexual activity such as unprotected sex.  
Sexual health targets  
The government set out a number of sexual health targets in the public health 
white paper ‘Choosing health’ (DH 2004). These form part of a public service 
agreement (PSA) with the Department of Health (DH) and include: 
• a reduction in the under 18 conception rate by 50% by 2010, as part of a 
broader strategy to improve sexual health 
• all patients contacting GUM clinics to be offered an appointment within 
48 hours by 2008  
• a decrease in the rate of new diagnoses of gonorrhoea  
• an increase in the percentage of people aged 15–24 accepting 
chlamydia screening by 2007.  
Reducing the under 18 conception rate is a joint PSA for the DH and the 
Department for Education and Skills (DfES 2004). It is also a national PSA for 
local government.  
Practice 
Figure 1 below provides a framework to use for sexual health services. It 
describes the context and desired outcomes. It also highlights the range of 
interventions (including those carried out on a one to one basis) which are 
designed to promote sexual health and deliver sexual health services.   
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Sexual Health Interventions FrameworkFigure 1
Local 
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and
networks 
for sexual 
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and the 
prevention 
of teenage 
pregnancies
National policies
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sexual health & HIV
• Teenage pregnancy
strategy
• Choosing health
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for HIV & sexual health
• National Chlamydia 
Screening Programme
Sexual health 
services
• Detection and 
management of STIs
including HIV
• Contraceptive advice
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• Pregnancy services 
and support
• Abortion services
• Reduce transmission 
of HIV and STIs
• Reduce prevalence
of undiagnosed
HIV and STIs
• Reduce unintended
pregnancy rates
• Reduce stigma
associated with 
HIV and other STIs
Sexual health 
programmes
• Health promotion
& social marketing
• Sex & relationship 
education 
• Community 
outreach work with 
vulnerable groups
Direct one
to one advice 
Trends & patterns
Prevalence & incidence of:
• STIs
• under 18 conceptions
Societal factors
• Public attitudes
• Cultural norms 
• Changes in family
structures
• Immigration patterns
• Advances in health 
technologies
Long-term
outcomes
Intermediate
outcomes
Factors
influencing
sexual behaviour
• Gender, sexuality,
age, life stage,
ethnicity 
• Related risk 
behaviours
• Attitudes, beliefs
• Perceived risks
• Safer sex practices 
including condom 
use
• Self-efficacy e.g. in 
condom negotiation
• Uptake of testing
and other sexual 
health services
• Partner notification,
testing & treatment
• Effective use of 
contraception
 
One to one interventions are integral to the modernisation of sexual health 
services.  
Figure 2 sets out the relationship and links between different one to one 
interventions for the prevention of STIs and under 18 conceptions. It places 
the recommendations (R1–6) in the context of current service provision. This 
provision is defined in the ‘National strategy for sexual health and HIV’ (DH 
2001) and national guidance documents such as the ‘Recommended 
standards for sexual health services’ (MedFASH 2005). 
High risk groups and
behaviours:
• men who have 
sex with men 
• alcohol and 
substance misuse
• early onset of 
sexual activity
• unprotected sex
• frequent change of
and/or multiple 
sexual partners
• people from - or 
who have visited -
areas of high
HIV prevalence
• vulnerable young 
people
Assess 
risk of STI 
infection
as part of 
routine care.
Where 
appropriate:
• advise on 
STI  testing
• offer sexual 
health advice 
and/or 
refer for 
consultation
Structured
discussion/s with
individual to 
agree risk 
reduction
strategy
For those with an STI: 
• infection-specific
information 
• testing, treatment and
follow up 
• partner notification
STI and HIV testing 
For vulnerable young 
people:
• information & advice 
on prevention of STIs
• information & advice 
on contraceptive 
methods
Regular home visits to 
vulnerable women (aged 
under 18 ) who are 
pregnant or mothers. Offer:
• information & advice 
on prevention of STIs and
contraceptive methods
• discuss education, train-
ing and employment
Who What 
R1
R2 R3
R4
R5
R6
• Voluntary & community 
organisations
• School clinics and other 
youth settings
• General practice 
• Community health 
services
• Community 
contraceptive services
• GUM services
• Antenatal and 
postnatal services
• Abortion services
Sexual health network defines respective role of services according to local capacity
A model for one to one interventions to prevent STIs and under 18 conceptions
Where
Figure 2
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The guidance is aimed at healthcare professionals working in the NHS who 
have a role in and/or responsibility for sexual health. It will also be relevant to 
non-NHS professionals and others with a responsibility for sexual health 
working in local authorities and the education, voluntary, community and 
private sectors. 
3 Considerations 
PHIAC took account of a number of factors and issues in making the 
recommendations. 
3.1 Much of the evidence is US-based. However, PHIAC considered that it 
was sufficiently applicable to the UK context to inform the 
recommendations. Members also considered the consistency of findings 
across the studies to assess the strength of evidence.  
3.2 PHIAC recognised that one to one inventions are only one element of a 
broader sexual health strategy that is needed to prevent STIs and under 
18 conceptions. PHIAC did not assess the relative effectiveness (and 
cost effectiveness) of one to one interventions versus other types of 
intervention. 
3.3 PHIAC considered that implementation of the recommendations will 
make an important contribution to the modernisation of sexual health 
services, in line with the ‘National strategy for sexual health and HIV’ 
(DH 2001). The guidance promotes universal provision of one to one 
sexual health interventions for the prevention and early detection of STIs 
and the prevention of under 18 conceptions. This should be part of the 
routine care offered in primary care (including that offered by enhanced 
services in general practice) and by contraceptive services. One to one 
sexual health interventions should also be provided by pharmacists who 
are trained in this area. (Again, they may provide this as part of 
enhanced services.)   
3.4 This guidance complements current developments concerned with the 
asymptomatic screening of STIs (such as the Chlamydia Screening 
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Programme and HIV testing). PHIAC recognised that individuals who are 
at risk of STIs need a choice of options, including rapid and open access 
to testing services, as well as one to one sexual health advice.  
 
It should be noted that PHIAC did not consider the effectiveness of the 
National Chlamydia Screening Programme. However, evidence relating 
to the effectiveness of one to one interventions in preventing chlamydia 
was considered. Specific recommendations on HIV testing and 
treatment were not within the scope of this guidance. 
3.5 People at risk of STIs can only benefit from sexual health services if they 
are accessible, convenient and confidential. It is important that services 
are developed in consultation with the client group. 
 
Vulnerable young people and individuals who engage in risky sexual 
behaviours tend not to attend primary care or community health services 
on a regular basis. Less traditional settings will need to be considered 
for the provision of sexual health services for these clients. Education, 
training, employment and youth services will all play an important role in 
pointing young people to sexual health services. 
3.6 The configuration of sexual health services will be dependent on local 
circumstances and capacities. Local sexual health networks will need to 
agree a suitable model of service delivery for the prevention and 
treatment of STIs and the prevention of under 18 conceptions. (STI 
services should cover testing, risk assessment, treatment of infection, 
partner notification and follow up.) This model should define the 
respective roles of primary care, community contraception services, 
specialist GUM and other services.  
 
PHIAC recognised that the recommendations do not stand alone. They 
should be implemented in conjunction with infection-specific prevention 
and treatment guidelines and protocols. When working with young 
people, the recommendations should be implemented with regard to the 
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Fraser guidelines ‘Gillick v West Norfolk & Wisbech AHA & DHSS 
(1985)’ and guidance produced by the Teenage Pregnancy Unit. 
3.7 The training requirements of those involved in delivering one to one 
sexual health interventions (within both NHS and non-NHS settings) will 
need to be assessed. Current training guidance and access to 
accredited courses should assist in meeting these requirements.  
4 Implementation 
The Healthcare Commission assesses the performance of NHS organisations 
in meeting core and developmental standards set by the DH in ‘Standards for 
better health’ issued in July 2004. The implementation of NICE public health 
guidance will help organisations meet the standards in the public health 
(seventh) domain in ‘Standards for better health’. These include the core 
standards numbered C22 and C23 and the developmental standard D13. In 
addition, implementation of NICE public health guidance will help meet the 
health inequalities target as set out in ‘The NHS in England: the operating 
framework for 2006/7’ (DH 2006). 
NICE has developed tools to help organisations implement this guidance. The 
tools will be available on our website (www.nice.org.uk/PHI003). 
• Costing tools: 
– costing report to estimate the national savings and costs 
associated with implementation 
– costing template to estimate the local costs and savings involved. 
• Slides highlighting key messages for local discussion. 
• Practical advice on how to implement the guidance and details of 
national initiatives that can provide support.  
• Audit criteria to monitor local practice. 
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5 Recommendations for research 
PHIAC notes that current UK and US research being undertaken on 
‘expedited partner therapy’ may inform future guidance in this area. The 
Committee recommends that the following research questions should be 
addressed in order to improve the evidence relating to one to one 
interventions in the UK.  
1. What are the most effective and cost-effective methods of – and tools 
for – identifying individuals at high risk of STIs and under 18 
conceptions? 
2. What are the key characteristics of an effective and cost-effective one 
to one discussion to reduce STIs and under 18 conceptions among 
people who engage in high risk behaviour?  
3. What is the relative effectiveness and cost effectiveness of one to one 
interventions delivered by different health professionals and in different 
settings? 
4. In the UK, what are the most effective and cost-effective methods of 
contacting, testing and treating partners of patients who have an STI, 
particularly those engaged in high risk behaviour?  
5. What utility scores should be applied to individuals with STIs and 
women who conceive under 18 to generate QALYs for use in cost-
effectiveness analysis? 
More detail on the evidence gaps identified during the development of this 
guidance is provided in appendix B. 
6 Updating the recommendations 
In March 2010, these recommendations will be reviewed and the state of the 
evidence base at that time will be reassessed. A decision will then be made 
about whether it is appropriate to update the guidance. If it is not updated at 
that time, the situation will be reviewed again in March 2012. 
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7 Related NICE guidance 
Postnatal care: routine postnatal care of women and their babies. NICE 
clinical guideline 37 (2006). Available from www.nice.org.uk/CG037
Long-acting reversible contraception. NICE clinical guideline 30 (2005). 
Available from www.nice.org.uk/CG030
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Appendix A: recommendations for policy and practice 
and supporting evidence statements 
This appendix sets out the recommendations and the associated evidence 
statements taken from three reviews of effectiveness (see appendix D for the 
key to study types and quality assessments). It also sets out a brief summary 
of findings from the economic appraisal and the fieldwork. 
The three reviews of effectiveness are: 
• Review 1: ‘Contraceptive advice and provision for the prevention of under 
18 conceptions and STIs: a rapid review’. 
• Review 2: ‘Rapid review of the evidence for the effectiveness of screening 
for genital chlamydia infection in sexually active young women and men’.  
• Review 3: ‘Rapid review of the evidence for the effectiveness of partner 
notification for sexually transmitted infections including HIV’. 
Recommendations are followed by the evidence statement(s) that underpin 
them. For example: (evidence statement 1.1) indicates that the linked 
statement is numbered 1 in the review ‘Contraceptive advice and provision for 
the prevention of under 18 conceptions and STIs: a rapid review’; (evidence 
statement 2.1) indicates that it is numbered 1 in the ‘Rapid review of the 
evidence for the effectiveness of screening for genital chlamydia infection in 
sexually active young women and men’ 
The reviews are available on the NICE website (www.nice.org.uk/PHI003). 
Where a recommendation is not directly taken from the evidence statements, 
but is inferred from the evidence, this is indicated by IDE (inference derived 
from the evidence). 
Recommendation 1 
Who is the target population? 
Key groups at risk of STIs including: 
• men who have sex with men 
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• people who have come from or who have visited areas of high HIV 
prevalence.  
Behaviours that increase the risk of STIs include: 
• misuse of alcohol and/or substances 
• early onset of sexual activity  
• unprotected sex and frequent change of and/or multiple sexual partners. 
Who should take action? 
Health professionals working in: 
• general practice  
• genito-urinary medicine (GUM)  
• community health services (including community contraceptive services) 
• voluntary and community organisations 
• school clinics.  
What action should they take? 
• Identify individuals at high risk of STIs using their sexual history. 
Opportunities for risk assessment may arise during consultations on 
contraception, pregnancy or abortion, and when carrying out a cervical 
smear test, offering an STI test or providing travel immunisation. Risk 
assessment could also be carried out during routine care or when a new 
patient registers.  
• Have one to one structured discussions with individuals at high risk of 
STIs (if trained in sexual health), or arrange for these discussions to take 
place with a trained practitioner.   
(Evidence statement 1.1, 1.2, 1.3, 1.4, 2.20, 2.21, 2.26, 2.29, IDE) 
Recommendation 2 
Who is the target population? 
Key groups at risk of STIs including: 
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• men who have sex with men 
• people who have come from or who have visited areas of high HIV 
prevalence.  
Behaviours that increase the risk of STIs include: 
• misuse of alcohol and/or substances 
• early onset of sexual activity  
• unprotected sex and frequent change of and/or multiple sexual partners. 
Who should take action? 
Health professionals trained in sexual health who work in: 
• general practice  
• GUM  
•  community health services (including community contraceptive services)  
• voluntary and community organisations 
•  school clinics.  
What action should they take? 
• Have one to one structured discussions with individuals at high risk of STIs. 
The discussions should be structured on the basis of behaviour change 
theories. They should address factors that can help reduce risk-taking and 
improve self-efficacy and motivation. Ideally, each session should last at 
least 15–20 minutes. The number of sessions will depend on individual 
need. 
For details of a range of behaviour change theories see ‘Predicting health 
behaviour’ (Conner and Norman 2005).  
(Evidence statement 1.1, 1.2, 1.3, 1.4, IDE) 
  24
Recommendation 3 
Who is the target population? 
Patients with an STI  
Who should take action? 
• Health professionals working in general practice, GUM and community 
health services (including community contraceptive services), voluntary and 
community organisations and school clinics. (However, they may need to 
refer the patient to a specialist.) 
• Specialists with responsibility for helping to contact, test and treat partners 
of patients with an STI (partner notification). They may be sexual health 
advisers, general practitioners (GPs) or practice nurses providing 
enhanced sexual health services, chlamydia screening coordinators or 
GUM clinicians. 
What action should they take? 
• Help patients with an STI to get their partners tested and treated (partner 
notification), when necessary. This support should be tailored to meet the 
patient’s individual needs.   
• If necessary, refer patients to a specialist with responsibility for partner 
notification. (Partner notification may be undertaken by the health 
professional or by the patient.) 
• Provide the patient and their partners with infection-specific information, 
including advice about possible re-infection. For chlamydia infection, also 
consider providing a home sampling kit. .  
(Evidence statement 3.1, 3.2, 3.8, 3.16, IDE) 
Recommendation 4 
Who is the target population? 
Population served by a PCT 
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Who should take action? 
PCT commissioners  
What action should they take? 
• Ensure that sexual health services, including contraceptive and abortion 
services, are in place to meet local needs. All services should include 
arrangements for the notification, testing, treatment and follow-up of 
partners of people who have an STI (partner notification). 
• Define the role and responsibility of each service in relation to partner 
notification (including referral pathways).  
• Ensure staff are trained.  
• Ensure there is an audit and monitoring framework in place.  
(Evidence statement 3.1, 3.2, 3.8, 3.16, IDE) 
Recommendation 5 
Who is the target population? 
Vulnerable young people aged under 18. This may include young people: 
• from disadvantaged backgrounds 
• who are in – or leaving – care  
• who have low educational attainment.  
For a more detailed definition of vulnerable young people see Department for 
Education and Skills (2006) ‘Teenage pregnancy: accelerating the strategy to 
2010’. 
Who should take action? 
• GPs, nurses and other clinicians working in healthcare settings such as 
primary care, community contraceptive services, antenatal and postnatal 
care, abortion and GUM services, drug/alcohol misuse and youth clinics, 
and pharmacies.  
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• GPs, nurses and other clinicians working in non-healthcare settings such 
as schools and other education and outreach centres.  
What action should they take? 
• Where appropriate, provide one to one sexual health advice on:   
− how to prevent and/or get tested for STIs and how to prevent 
unwanted pregnancies 
- all methods of reversible contraception, including long-acting 
reversible contraception (LARC) (in line with NICE clinical 
guideline 30) 
- how to get and use emergency contraception 
- other reproductive issues and concerns. 
• Provide supporting information on the above in an appropriate format.   
(Evidence statement 1.3, 1.4, 1.18, 1.19, IDE) 
Recommendation 6 
Who is the target population? 
Vulnerable young women aged under 18 who are pregnant or who are already 
mothers. This may include young women:  
• from disadvantaged backgrounds 
• who are in – or leaving – care  
• who have low educational attainment.  
For a more detailed definition of vulnerable young people see Department for 
Education and Skills (2006) ‘Teenage pregnancy: accelerating the strategy to 
2010’. 
Who should take action? 
Midwives and health visitors who provide antenatal, postnatal and child 
development services  
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What action should they take? 
• Regularly visit vulnerable women aged under 18 who are pregnant or who 
are already mothers.  
• Discuss with them and their partner (where appropriate) how to prevent or 
get tested for STIs and how to prevent unwanted pregnancies. The 
discussion should cover: 
- all methods of reversible contraception, including LARC (in line 
with NICE clinical guideline 30), and how to get and use 
emergency contraception  
- health promotion advice, in line with NICE guidance on postnatal 
care (NICE clinical guideline 37) 
- opportunities for returning to education, training and employment 
in the future. 
• Provide supporting information in an appropriate format.  
• Where appropriate, refer the young woman to the relevant agencies, 
including services concerned with reintegration into education and work.  
(Evidence statement 1.17, IDE) 
Evidence statements  
Evidence statement 1.1 
In summary, the evidence on the effectiveness of one to one interventions for 
the prevention of STIs is mixed but, on balance, marginally supports the 
interventions. There is evidence from Project RESPECT a large (++) US study 
(Kamb 1998) that both a two session and a four session one to one 
counselling intervention can reduce STIs in the long and very long term in 
heterosexuals, and from one (+) study that STIs in men can be reduced in the 
long term after one 90 minute session (Kalichman). However, the effect 
appears to decrease over time, with one study finding a reduction in effect 
after 6 months (Kamb 1998).  
RESPECT intervention model 
This comprised brief or enhanced counselling sessions. The brief intervention 
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consisted of two, 20 minute, client-focused interactive sessions with a 
counsellor. It involved negotiating an acceptable and achievable risk-reduction 
plan that focused on condom use. The enhanced counselling consisted of four 
interactive sessions with a counsellor, based on the theory of reasoned 
action. The sessions took place over a 2 week period. The first lasted 20 
minutes, the remainder were 60 minutes long. They involved negotiating a 
long-term plan for behaviour change. The aim was to ensure condoms were 
consistently used. Both types of counselling helped change the attitudes and 
self-efficacy (determining intention) of women who attended. Only the more 
intensive counselling was effective for men. The models of behaviour change 
underpinning RESPECT were the social cognitive theory and the theory of 
reasoned action.  
Evidence statement 1.2 
In addition EXPLORE, a large (++) US study of ten sessions of one to one 
counselling for MSM [men who have sex with men], found a 15.7% reduction 
in HIV infection but this was not statistically significant (EXPLORE 2004). The 
other studies found no effect on STIs, but may have been underpowered for 
this outcome.   
EXPLORE intervention model 
The intervention consisted of 10 core counselling modules delivered at one to 
one counselling sessions, over a 4–6 month period. Typically, one module 
was delivered per session. After the initial 10 modules, maintenance sessions 
were delivered every 3 months. The intervention was designed to address the 
individual, interpersonal and other factors associated with risk taking by some 
men who have sex with men. These factors include: the greater pleasure 
derived from risky sexual behaviour; negative mood states; communication 
difficulties; social norms that encourage misperceptions of risk and risk taking; 
use of alcohol or recreational drugs; and life events and environments that are 
catalysts for risk taking. The intervention was carried out by counsellors who 
had completed the required 40 hours of training specified by the intervention 
protocol. 
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Evidence statement 1.3 
Interventions with adolescents appeared to be particularly effective. A 
subgroup analysis of Project RESPECT (Bolu 2004) found a significant 
reduction in sexually transmitted infections with both the four and two session 
interventions versus a didactic control. Although this was the only study to 
show a statistically significant difference, the general trend in this group of 
studies was towards a reduction in STIs. 
Evidence statement 1.4 
Twenty five studies reported condom use, of which only eight showed a 
statistically significant increase in condom use in the intervention group 
compared to the control. However, overall there is weak evidence (that is, it is 
mixed or conflicting but on balance marginally supports) that one to one 
STI/HIV prevention interventions can increase short and long-term condom 
use compared to control. Project RESPECT, a large good quality (++) US 
study found an increase in condom use in both the four and two session 
counselling intervention groups compared to a didactic control (Kamb 1998). 
However, several studies found the effect of an intervention appears to 
decrease or disappear over time. Greater uniformity is needed in the way in 
which condom use is measured in studies.  
(For details of the RESPECT intervention model see page 23.) 
Evidence Statement 1.17   
Six studies evaluated interventions to support pregnant women or mothers.  
Although only two of the studies focused solely on adolescents (O’Sullivan 
1992, Quinlivan 2003) all included at least 40% of adolescents and focused 
on disadvantaged, low income women. There is good evidence that multi-
session support and home visiting for disadvantaged low income pregnant 
women or mothers can prevent repeat pregnancies with two (+) (Olds 2002; 
Olds 2004) and one (-) (O’Sullivan 1992) studies showing a significant 
reduction in repeat pregnancies in the intervention group compared to control. 
In addition one (-) study (Olds 1997) found a reduction in repeat pregnancies 
in poor unmarried women, although not in the sample as a whole. 
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Evidence Statement 1.18 
In relation to the prevention of pregnancy, two (-) studies evaluated 
contraception advice and support in a clinic-based setting (Shlay 2003; Winter 
1991). Neither found a significant reduction in pregnancies but both showed a 
trend towards a reduction in the intervention group compared to control. 
Evidence Statement 1.19  
Seven studies reported contraception use. This was measured in various 
different ways, including oral contraception, emergency contraception (EC) 
and condom use. Four studies showed a statistically significant effect on 
contraception use. Two increased oral contraceptive use. These were a (++) 
RCT (Quinlivan 2003) and a (+) RCT (Danielson 1990) that found one to one 
interventions with teenagers can improve contraception use in the long term. 
Of the two (++) studies of advanced provision of EC, one (Harper 2005) found 
an increase in the use of EC at 6 month follow-up and the other (Gold 2004) 
found a short term increase in EC use but this was no longer significant at 6 
months. This study (Gold 2004) also reported an increase in condom use but 
no significant difference in use of the oral contraceptive pill (Gold 2004). In the 
other studies the general trend was towards an increase in contraception use 
although one (-) study found the effect on contraception use was no longer 
significant at 12 months (Winter 1991). Therefore, there is some evidence that 
one to one interventions with under 18s can increase contraception use.  
Evidence Statement 2.20 
There is evidence from two (+) controlled trials (one randomised, one non-
randomised) that offering chlamydia testing in general practice increases the 
number of young women and men screened compared with usual care. This 
evidence applies to women and men under 30 years attending general 
practices. 
Evidence Statement 2.21 
There is evidence from two (+) randomised controlled trials (one large, one 
small) suggesting that changing systems of health service delivery can 
increase the numbers of teenage women screened opportunistically, and the 
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number of chlamydia cases detected. This evidence applies to sexually active 
young women under 20 years attending general paediatric or teen clinics. 
Evidence Statement 2.26 
Descriptive studies in general practice (two studies, one ++, one +) suggest 
that offering GPs incentives [to screen patients] might increase acceptance 
rates by patients. There were too few studies to be able to say anything about 
the effects of incentives on effective screening rates. 
Evidence Statement 2.29 
Data from one (+) randomised controlled trial, one (++) descriptive study, and 
three (+) descriptive studies (one + contradictory study) show that less than 
half of women and men under 25 years attending general practice get 
screened for chlamydia because not all those who are eligible for screening 
are offered a test.   
Evidence Statement 3.1 
There is evidence from four large randomised controlled trials (two +; two -) 
that patient delivered partner therapy, plus additional information for partners, 
reduces persistent or recurrent infections in women and men diagnosed with 
gonorrhoea or chlamydia by approximately 5% compared to patient referral 
(either minimal or supplemented by contact card). 
Evidence Statement 3.2 
There is evidence from one large randomised controlled trial (-) that patient 
referral, supplemented by additional information about infection for index 
patients and partner(s), reduces persistent or recurrent infections in men 
diagnosed with gonorrhoea or chlamydia by approximately 5% when 
compared to minimal patient referral. 
Evidence Statement 3.8 
There is weak evidence from two randomised controlled trials (both -) that 
giving index patients diagnosed with chlamydia sampling kits for their 
partner(s) can increase the number of partners who get tested, when 
compared to getting the partner(s) to visit their doctor for testing. 
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Evidence Statement 3.16 
There is evidence from one randomised controlled trial (++) that patient 
referral for patients with chlamydia conducted in general practice is at least as 
effective, in terms of partners who get treated, when compared to referring 
patients to a specialist health service. 
Cost-effectiveness evidence  
Overall, one to one interventions were found to be cost effective. The results 
of the cost-effectiveness analysis are summarised below. 
STI counselling interventions  
Most of the brief STI counselling interventions appear cost effective when 
compared with ‘usual treatment’ (using £30,000 per QALY as the threshold).  
The incremental analysis demonstrated that brief interventions involving 
information giving or developing motivation and behavioural skills (particularly 
among women) produce the greatest benefits for the least cost. More 
intensive behavioural skills counselling and enhanced counselling appear to 
be least cost effective. These analyses apply to the general population, 
including vulnerable young women.  
 
In the absence of data, no costs were attributed to ‘usual treatment’. As a 
result, when interventions are compared against usual treatment the cost 
difference may be overestimated and the incremental cost-effectiveness ratios 
may be artificially high.   
The loss of quality of life (QALYs lost) is particularly important in the analysis.   
The cost per QALY may be high (if low values are assigned to the change in 
quality of life) but brief STI counselling falls below a £30,000 per QALY 
threshold (based on 0.1 of a QALY change). 
Partner notification at GP clinics 
Partner notification by a practice nurse in a general practice costs the same 
as in a GUM setting – but more patients can be treated in a GP setting. 
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Fieldwork Findings  
Fieldwork aimed to test the relevance, usefulness and the feasibility of 
implementing the recommendations and the findings were considered by 
PHIAC in developing the final recommendations. The fieldwork was 
conducted with practitioners and commissioners involved in sexual health 
services. They included practitioners working across youth, community and 
clinical settings in the NHS, local authorities and the voluntary sector. The 
fieldwork report is at: www.nice.org.uk/PHI003
Fieldwork participants who work with young people were overwhelmingly 
positive about the recommendations and their potential to help reduce STIs 
and under 18 conceptions. Many participants stated that the 
recommendations were already part of current practice. (Those working in 
general practice were least likely to be involved in STI prevention.)  
The recommendations were viewed as reinforcing aspects of the 
modernisation agenda for sexual health, particularly in relation to the: 
• identification of asymptomatic sexually transmitted infections 
• role of primary and community services in providing level 1 and 2 
sexual health services, as defined by the ’National strategy for sexual 
health and HIV’ 
• provision of choice of referral for STI testing and treatment 
• promotion of the use of long-acting reversible contraception methods 
and information about the availability and use of emergency 
contraception 
• increased integration of STI prevention and community contraceptive 
services.  
While practitioners and commissioners did not view the recommendations as 
offering a new approach, these interventions have not been implemented 
universally. Wider and more systematic implementation would be achieved if 
there was/were: 
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• a clearer definition of the nature of one to one interventions (offering 
details such as, ‘what should be done, who should carry it out and 
where?’) 
• information about the relative effectiveness of one to one interventions 
versus other options 
• information about how the recommendations might help meet the 
national GUM 48 hour access target 
• recognition of the need for open access to STI testing,  and the general  
need for acceptable, accessible and confidential sexual health services 
• recognition of the need for local flexibility in service provision 
• incentives to encourage GPs to get involved  in STI prevention 
• provision of and/or access to training opportunities to develop 
competencies for the delivery of sexual health interventions. 
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Appendix B: gaps in the evidence 
PHIAC identified a number of gaps in the evidence relating to the one to one 
interventions under examination, in particular, from the UK, based on an 
assessment of the evidence, stakeholder comments and fieldwork. These are 
set out below.  
1. More rigorous evaluation of the effectiveness and cost effectiveness of 
one to one interventions to prevent STIs (including HIV) and under 18 
conceptions in the UK. Studies should be sufficiently powered to detect 
a reduction in STI infections and conceptions. They should include the  
following:   
– interventions by different health professionals in different 
settings (for example, in schools, youth and outreach settings)  
– peer led interventions  
– interventions aimed at vulnerable groups.  
2. A comparison of the relative effectiveness and cost effectivness of one 
to one and group interventions aimed at reducing STIs and unintended 
teenage pregnancies. 
3. An evaluation of the most effective and cost effective ways of 
communicating sexual health information to young people and the 
wider public. In particular, an assessment of effective and cost effective 
ways of addressing the stigma and discrimination surrounding sexual 
health issues.  
4. An evaluation of the relative effectiveness and cost effectiveness of 
proactive and opportunistic screening to detect, prevent and reduce 
chlamydia. 
5. An evaluation of the relative effectiveness and cost effectiveness of 
different methods of partner notification.  
6. Generation of QALYs for use in cost-effectiveness analysis by deriving 
utility scores for individuals with STIs and for underage conception. 
  36
Utility scores need to be quantified for the UK population as a whole 
and among high risk groups (for example, for re-infection and multiple 
infection rates and the incidence of other health complications). 
7. Studies to reflect the effects of onward transmission of STIs, using 
dynamic (rather than static) modelling to capture re-infection rates and 
further health consequences.         
PHIAC made 5 recommendations for research. These are listed in section 5. 
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Appendix C: membership of the Public Health 
Interventions Advisory Committee (PHIAC), the NICE 
Project Team and external contractors  
Public Health Interventions Advisory Committee (PHIAC) 
NICE has set up a standing committee, the Public Health Interventions 
Advisory Committee (PHIAC), which reviews the evidence and develops 
recommendations on public health interventions. Membership of PHIAC is 
multidisciplinary, comprising public health practitioners, clinicians (both 
specialists and generalists), local authority employees, representatives of the 
public, patients and/or carers, academics and technical experts as follows.  
Mrs Cheryll Adams Professional Officer for Research and Practice 
Development with the Community Practitioners' and Health Visitors' 
Association (CPHVA) 
Professor Sue Atkinson CBE Independent Consultant and Visiting Professor 
in the Department of Epidemiology and Public Health, University College 
London 
Professor Michael Bury Emeritus Professor of Sociology at the University of 
London and Honorary Professor of Sociology at the University of Kent  
Professor Simon Capewell Chair of Clinical Epidemiology, University of 
Liverpool 
Professor K K Cheng Professor of Epidemiology, University of Birmingham 
Mr Philip Cutler Forums Support Manager, Bradford Alliance on Community 
Care 
Professor Brian Ferguson Director of the Yorkshire and Humber Public 
Health Observatory  
Professor Ruth Hall Regional Director, Health Protection Agency, South 
West 
Ms Amanda Hoey Director, Consumer Health Consulting Limited 
Mr Andrew Hopkin Senior Assistant Director for Derby City Council 
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Dr Ann Hoskins Deputy Regional Director of Public Health for NHS North 
West 
Ms Muriel James Secretary for the Northampton Healthy Communities 
Collaborative and the King Edward Road Surgery Patient Participation Group 
Professor David R Jones Professor of Medical Statistics in the Department 
of Health Sciences, University of Leicester 
Dr Matt Kearney General Practitioner, Castlefields, Runcorn and GP Public 
Health Practitioner, Knowsley  
Ms Valerie King Designated Nurse for Looked After Children for Northampton 
PCT, Daventry and South Northants PCT and Northampton General Hospital. 
Public Health Skills Development Nurse for Northampton PCT 
CHAIR Dr Catherine Law Reader in Children’s Health, Institute of Child 
Health, University College London 
Ms Sharon McAteer Health Promotion Manager, Halton PCT 
Professor Klim McPherson Visiting Professor of Public Health 
Epidemiology, Department of Obstetrics and Gynaecology, University of 
Oxford 
Professor Susan Michie Professor of Health Psychology, BPS Centre for 
Outcomes Research & Effectiveness, University College London 
Dr Mike Owen General Practitioner, William Budd Health Centre, Bristol 
Ms Jane Putsey Lay Representative. Chair of Trustees of the Breastfeeding 
Network  
Dr Mike Rayner Director of British Heart Foundation Health Promotion 
Research Group, Department of Public Health, University of Oxford 
Mr Dale Robinson Chief Environmental Health Officer, South 
Cambridgeshire District Council 
Professor Mark Sculpher Professor of Health Economics at the Centre for 
Economics (CHE), University of York 
Dr David Sloan Retired Director of Public Health 
Dr Dagmar Zeuner Consultant in Public Health, Islington PCT 
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Expert cooptees to PHIAC: 
Dr Helen Ward Clinical Senior Lecturer,  Division of Epidemiology, Public 
Health and Primary Care, Imperial College London 
Dr Richard Ma General Practitioner, London  
Ms Kate Quail Regional Teenage Pregnancy Coordinator, East Midlands 
Dr Angela Robinson Consultant in Genito-Urinary Medicine, London 
Expert testimony to PHIAC:  
Mary Mcintosh Director, National Chlamydia Screening Programme 
Ian Simms Scientific Adviser, National Chlamydia Screening Programme 
Professor Catherine Peckham National Screening Committee  
NICE Project Team  
Mike Kelly 
CPHE Director 
Antony Morgan  
Associate Director  
Geraldine McCormick 
Analyst  
Amanda Killoran  
Analyst 
Bhash Naidoo  
Technical Adviser (Health Economics). 
External contractors 
External reviewers 
The Universities of Hertfordshire and Berne carried out the reviews of the 
evidence of effectiveness. The principal authors were: Francis Bunn and 
Fiona Brooks (review 1) of the University of Hertfordshire; Nicola Low and 
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Nichole Bender (review 2) of the University of Berne; and Sven Trelle and 
Aijing Shang (review 3), also from the University of Berne.  
NERA Consultancy carried out the cost-effectiveness review. The authors 
were: David Lewis, Leela Barham and Nicholas Latimer. 
The University of Birmingham produced a modelling report on an economic 
evaluation of opportunistic screening for chlamydia. The authors were: 
Pelham Barton and Tracey Roberts. 
Fieldwork 
The fieldwork was carried out by SHM Ltd and Liverpool John Moores 
University.    
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Appendix D: summary of the methods used to develop 
this guidance 
Introduction 
The reports of the reviews and economic appraisal include full details of the 
methods used to select the evidence (including search strategies), assess its 
quality and summarise it. 
The minutes of the PHIAC meetings provide further detail about the 
Committee’s interpretation of the evidence and development of the 
recommendations. 
All supporting documents are listed in appendix E and are available from the 
NICE website at: www.nice.org.uk/PHI003
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The guidance development process 
The stages of the guidance development process are outlined in the box 
below: 
1. Draft scope  
2. Stakeholder meeting  
3. Stakeholder comments  
4. Final scope and responses published on website 
5. Reviews and cost-effectiveness modelling 
6. Synopsis report of the evidence (executive summaries and evidence tables) 
circulated to stakeholders for comment 
7. Comments and additional material submitted by stakeholders 
8. Review of additional material submitted by stakeholders (screened against 
inclusion criteria used in reviews)  
9. Synopsis, full reviews, supplementary reviews and economic modelling 
submitted to PHIAC 
10. PHIAC produces draft recommendations 
11. Draft recommendations published for comment by stakeholders and for 
field testing 
12. PHIAC amends recommendations 
13. Responses to comments published 
14. Final guidance published on website 
Key questions 
The key questions were established as part of the scope. They formed the 
starting point for the reviews of evidence and facilitated the development of 
recommendations by PHIAC. The overarching question was: How can one to 
one interventions contribute to the reduction of STIs (including HIV) and the 
reduction of the rate of under 18 conceptions? The subsidiary questions were: 
1. What is the aim/objective of the intervention? What is it trying to change?  
2. What outcome measures are used to assess effectiveness? How valid 
and appropriate are they?  
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3. What is the content of the intervention? Does it influence effectiveness? 
4. Does the way it is carried out (the type/mode of communication, for 
example) influence effectiveness? 
5. Does effectiveness depend on the job title/position or other factors such 
as age, gender, sexuality or ethnicity of the deliverer (leader)? What are 
the significant features of an effective deliverer (leader)? 
6. Does the site/setting of delivery influence effectiveness? 
7. Does the intensity, length or frequency influence effectiveness/duration of 
effect? 
8. Does effectiveness vary according to age, gender, sexuality, socio-
economic status or ethnicity of target audience? 
9. What evidence is there on cost effectiveness? 
10. What are the barriers to implementing effective interventions? 
These questions were refined further in relation to the topic of each review 
(see reviews for further details). 
Reviewing the evidence of effectiveness 
Three reviews of effectiveness were conducted.  
Review 1 ‘Contraceptive advice and provision for the prevention of under 18 
conceptions and STIs: a rapid review’. 
Review 2 ‘Review of evidence for the effectiveness of screening for genital 
chlamydial infection in sexually active young women and men’. 
Review 3 ‘Review of evidence for the effectiveness of partner notification for 
sexually transmitted infections including HIV’.  
Identifying the evidence  
The following core databases were searched for randomised controlled trials, 
controlled before/after studies and qualitative studies (process only): Medline, 
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Embase, Psychinfo, DARE and Sigle from 1990–2005. Reference lists from 
included studies were hand searched.  
Further details of databases, search terms and strategies are included in the 
review reports.  
Selection criteria 
Inclusion and exclusion criteria for each review varied and details can be 
found at: www.nice.org.uk/PHI003
However, in general: 
• review 1 included one to one interventions which offered information, 
advice, condoms, counselling, cognitive behavioural therapy and/or 
activities that increase self-confidence, self-esteem and skill 
development 
• review 2 considered any activity described as screening or where 
testing for chlamydia was offered to asymptomatic sexually active 
adults 
• review 3 considered any intervention described as partner notification 
or contact tracing, or where partners were located and informed that 
they have been exposed to an infection 
• studies in both NHS and non-health settings were considered. Details 
of the studies that were excluded can be found in the reviews.  
Quality appraisal 
Included papers were assessed for methodological rigour and quality using 
the NICE methodology checklist, as set out in the NICE technical manual 
‘Methods for development of NICE public health guidance’ (see appendix E). 
Each study was described by study type and graded (++, +, -) to reflect the 
risk of potential bias arising from its design and execution. 
Study type 
• Meta-analyses, systematic reviews of RCTs or RCTs (including cluster 
RCTs). 
  45
• Systematic reviews of, or individual, non-randomised controlled trials, 
case-control studies, cohort studies, controlled before-and-after (CBA) 
studies, interrupted time series (ITS) studies, correlation studies.  
• Non-analytical studies (for example, case reports, case series). 
• Expert opinion, formal consensus. 
Study quality 
++  All or most of the criteria have been fulfilled. Where they have not been 
fulfilled the conclusions are thought very unlikely to alter. 
+  Some criteria have been fulfilled. Those criteria that have not been 
fulfilled or not adequately described are thought unlikely to alter the 
conclusions. 
-  Few or no criteria fulfilled. The conclusions of the study are thought 
likely or very likely to alter. 
The studies were also assessed for their applicability to the UK. 
Summarising the evidence and making evidence statements 
Data from the reviews was summarised in evidence tables (see full reviews 
and the synopsis). Outcomes of interest included: 
• review 1: reductions in under 18 teenage conceptions and STIs 
including HIV (primary outcomes), and increased condom use, 
improved sexual health knowledge, and a reduction in the number of 
sexual partners and general sexual risk taking (intermediate outcomes)  
• review 2: reduction in the prevalence and incidence of chlamydia and 
female reproductive tract morbidity 
• review 3: reduction in the incidence and prevalence of STI (patient and 
index patient), increase in number of partners contacted, tested and 
treated.  
The findings from the reviews were synthesised and used as the basis for a 
number of evidence statements relating to each key question. The evidence 
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statements reflect the strength (quantity, type and quality) of evidence and its 
applicability to the populations and settings in the scope. 
Economic appraisal 
The economic appraisal consisted of a review of economic evaluations and a 
cost-effectiveness analysis. 
Review of economic evaluations 
A systematic search was carried out on four databases from January 1990 to 
December 2005: Econlit, NHS HEED, NEED, DARE. The results of these 
searches were supplemented by results from the parallel effectiveness 
reviews and additional papers identified by NICE. The main inclusion criteria 
were: 
• studies focused on one to one interventions 
• studies set in countries in Europe, US, Canada and Australia 
• studies set in prison, army, primary care and secondary care settings. 
Included studies were assessed for quality using a checklist based on the 
criteria developed by Drummond et al. (1997). Studies were then given a 
score (++, +, -) to reflect the risk of potential bias arising from its design and 
execution. The evidence tables for the cost-effectiveness review are included 
in the review (see appendix E).  
Cost-effectiveness analysis 
Economic models were constructed to incorporate data from the reviews of 
effectiveness and cost effectiveness. The results are reported in ‘PHIAC 6.7 
economic modelling report’ (University of Birmingham) and ‘PHIAC 6.10 
economic modelling report’ (NERA consultancy). They are available on the 
NICE website at: www.nice.org.uk/PHI003
Fieldwork 
Fieldwork was carried out to evaluate the relevance and usefulness of NICE 
guidance for practitioners and the feasibility of implementation. It was 
conducted with practitioners and commissioners who are involved in sexual 
  47
health services. They included those working across youth, community and 
clinical settings in the NHS, local authorities and voluntary sector. 
The fieldwork comprised: 
• a qualitative study using structured focus groups in Birmingham, Leeds, 
Bristol and Plymouth, carried out by SHM Ltd. 
• an online Delphi study carried out in the North West and London 
regions by John Moores University. 
The two studies were commissioned to ensure there was ample geographical 
coverage. The main issues arising from these two studies are set out in 
appendix A under ‘Fieldwork findings’. The full fieldwork report is available on 
the NICE website: www.nice.org.uk/PHI003
How PHIAC formulated the recommendations 
At its meetings in May 2006 and September 2006 PHIAC considered the 
evidence of effectiveness and cost effectiveness. In addition, at its meeting in 
December 2006, it considered comments from stakeholders and the results 
from fieldwork to determine: 
• whether there was sufficient evidence (in terms of quantity, quality and 
applicability) to form a judgement 
• whether, on balance, the evidence demonstrates that the intervention is 
effective or ineffective, or whether it is equivocal 
• where there is an effect, the typical size of effect. 
PHIAC developed draft recommendations through informal consensus, based 
on the following criteria. 
• Strength (quality and quantity) of evidence of effectiveness and its 
applicability to the populations/settings referred to in the scope. 
• Effect size and potential impact on population health and/or reducing 
inequalities in health. 
• Cost effectiveness (for the NHS and other public sector organisations). 
• Balance of risks and benefits. 
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• Ease of implementation and the anticipated extent of change in 
practice that would be required. 
Where possible, recommendations were linked to an evidence statement(s) 
(see appendix A for details). Where a recommendation was inferred from the 
evidence, this was indicated by the reference ‘IDE’ (inference derived from the 
evidence). 
The draft guidance, including the recommendations, was released for 
consultation in October and November 2006. The guidance was signed off by 
the NICE Guidance Executive in February 2007. 
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Appendix E: supporting documents 
Supporting documents are available from the NICE website 
(www.nice.org.uk/PHI003). These include the following. 
• Review of effectiveness 
• Economic analysis: review and modelling reports 
• Fieldwork report 
• A quick reference guide for professionals whose remit includes public 
health and for interested members of the public. This is also available 
from the NHS Response Line (0870 1555 455 – quote reference 
number N1186).  
Other supporting documents include: 
•  ‘Methods for development of NICE public health guidance’ available 
from: www.nice.org.uk/page.aspx?o=299970 
• ‘The public health guidance development process: An overview for 
stakeholders including public health practitioners, policy makers and 
the public’ available from: www.nice.org.uk/page.aspx?o=299973 
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